A Study of LY3039478 in Healthy Participants

NCT02659865 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Placebo
DRUG: LY3039478 Capsule Formulation (Formulation 3)
DRUG: LY3039478 Drug-in Capsule (Reference, Formulation 1)
DRUG: LY3039478 Formulated Capsule (Test, Formulation 3)

Sponsor

Eli Lilly and Company